Clinical Application of F-18 FLT PET in Pediatric Brain Tumors

Abstract Archives of the RSNA, 2014

PDE175

Clinical Application of F-18 FLT PET in Pediatric Brain Tumors

Education Exhibits

Presented in 2014

Participants

Yoshihiro Nishiyama MD, Presenter: Nothing to Disclose

Yuka Yamamoto MD, PhD, Abstract Co-Author: Nothing to Disclose

TEACHING POINTS

The nucleoside analogue 3'-deoxy-3'-18F-fluorothymidine (FLT) with PET has been introduced for imaging cell proliferation. The purpose of this exhibit is: 1. To assess the clinical value of FLT PET in pediatric patients with brain tumors 2. To compare the uptake of C-11 methionine (MET) PET

TABLE OF CONTENTS/OUTLINE

1. FLT PET imaging in pediatric patients with brain tumors - Cerebellar astrocytoma - Medulloblastoma - Craniopharyngioma - Ependymoma - Germinoma - Brainstem glioma 2. Follow-up FLT PET imaging after therapy 3. Tumor recurrence vs. radiation necrosis

PDF UPLOAD

http://abstract.rsna.org/uploads/2014/14012856/14012856_1rpr.pdf

Cite This Abstract

Nishiyama, Y, Yamamoto, Y, Clinical Application of F-18 FLT PET in Pediatric Brain Tumors. Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14012856.html